Not sad enough for a depression trial? A systematic review of depression measures and cut points in clinical trial registrations

A network meta‐analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression

(2020) Pim Cuijpers et al.   World Psychiatry

Interpreting Patient-reported Outcome Scores for Clinical Research and Practice

(2019) Qiuling Shi et al.   MEDICAL CARE

Have Treatment Studies of Depression Become Even Less Generalizable? Applying the Inclusion and Exclusion Criteria in Placebo-Controlled Antidepressant Efficacy Trials Published over 20 Years to a Clinical Sample

(2019) Mark Zimmerman et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis

(2019) Klaus Munkholm et al.   BMJ Open

Are studies of psychotherapies for depression more or less generalizable than studies of antidepressants?

(2018) Lorenzo Lorenzo-Luaces et al.   JOURNAL OF AFFECTIVE DISORDERS

Are self-report scales as effective as clinician rating scales in measuring treatment response in routine clinical practice?

(2018) Mark Zimmerman et al.   JOURNAL OF AFFECTIVE DISORDERS

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

(2018) Andrea Cipriani et al.   LANCET

Was Eysenck right after all? A reassessment of the effects of psychotherapy for adult depression

(2018) P. Cuijpers et al.   Epidemiology and Psychiatric Sciences

How depressed is “depressed”? A systematic review and diagnostic meta-analysis of optimal cut points for the Beck Depression Inventory revised (BDI-II)

(2018) Michael von Glischinski et al.   QUALITY OF LIFE RESEARCH

Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter!

(2018) Michael P. Hengartner et al.   Frontiers in Psychiatry

Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants’ Efficacy and Harm

(2017) Michael P. Hengartner   Frontiers in Psychiatry

From neuroleptics to neuroscience and from Pavlov to psychotherapy: more than just the “emperor's new treatments” for mental illnesses?:

(2016) Jürgen Margraf et al.   EMBO Molecular Medicine

Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling

(2016) Mark Zimmerman et al.   JOURNAL OF AFFECTIVE DISORDERS

A simulation study into the performance of “optimal” diagnostic thresholds in the population:“Large” effect sizes are not enough

(2014) Gerrit Hirschfeld et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Psychometric properties of the Beck Depression Inventory-II: a comprehensive review

(2014) Yuan-Pang Wang et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Assessment of depression in medical patients: A systematic review of the utility of the Beck Depression Inventory-II

(2013) YP Wang et al.   Clinics

Minimally Clinically Significant Differences for Adolescents With Chronic Pain—Variability of ROC-Based Cut Points

(2013) Gerrit Hirschfeld et al.   JOURNAL OF PAIN

SELF-REPORT AND CLINICIAN-RATED MEASURES OF DEPRESSION SEVERITY: CAN ONE REPLACE THE OTHER?

(2012) Rudolf Uher et al.   DEPRESSION AND ANXIETY

Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials

(2009) Sylvain Mathieu   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The relationship of demographic, clinical, cognitive and personality variables to the discrepancy between self and clinician rated depression

(2009) Janet D. Carter et al.   JOURNAL OF AFFECTIVE DISORDERS

Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

(2008) Irving Kirsch et al.   PLOS MEDICINE